Press Releases

Clinical trial uses immunotherapy to treat mesotheliomaYesterday
The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute is looking for malignant pleural mesothelioma patients to try a new treatment that combines immunotherapy with a new drug that accelerates cell death.
Anal cancer precursors for women with HIV greater than previously reportedJul 12, 2019
The prevalence of anal high-grade squamous intraepithelial lesions, which precede anal cancer, is much higher in women living with HIV than previously reported.
Expert dispels common colorectal cancer surgery mythsJun 27, 2019
Dr. Atif Iqbal dispels some common myths and explains how Baylor College of Medicine's multidisciplinary approach to treating these cancers improves patient outcomes.
Study reveals elevated cancer risk in children with birth defectsJun 20, 2019
A collaborative team of scientists led by Baylor College of Medicine has assembled the largest study to date to evaluate cancer risk in children with birth defects.
Viswanathan receives NIH grant to study treatment for cancer-related pain Jun 20, 2019
Dr. Ashwin Viswanathan has been awarded a Research Project Grant (R01) of more than $2 million by the National Institutes of Health.
Cancer immunotherapy clinical study approved for phase 1Jun 7, 2019
A cancer immunotherapy research group at Baylor College of Medicine has secured Investigational New Drug regulatory clearance through the FDA to perform phase I clinical studies in newly-diagnosed adult patients with glioblastoma.
Study searches for families with gliomaMay 15, 2019
Gliogene, a study that aims to identify hereditary links of glioma, a rare and deadly form of brain cancer, has begun recruiting families affected by the disease in order to identify genes that contribute to its onset and inform susceptibility.
Ethical concerns of oncology trial-finding appsMay 13, 2019
In a new study, ethics scholar Dr. Stephanie Morain explores a trend of oncology trial recruitment via mobile apps, and what these app companies and consumers need to consider in terms of privacy and data protection
First-in-human trial shows promise in treating neuroblastomaApr 30, 2019
In a promising development, researchers released initial findings from the first two patients treated in a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma.
Colon cancer proteins, genes uncover potential treatmentsApr 25, 2019
Analyzing both the entire set of genes and all the proteins produced by colon cancer tissues from patient samples has revealed a more comprehensive view of the tumor that points at novel cancer biological mechanisms and possible new therapeutic strategies.
Shortages of pediatric cancer medicines threaten outcomesMar 4, 2019
Shortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients and hospitals across the country.
Cancer Prevention & Research Institute of Texas awards grantsFeb 22, 2019
The Cancer Prevention and Research Institute of Texas has awarded a combined $9,266,605 for seven projects in breast cancer, childhood cancers, T Cell therapy and lung cancer prevention.
Stand Up To Cancer Dream Team tackles T-cell lymphomaJan 29, 2019
Stand Up To Cancer announced at the annual SU2C Scientific Summit the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma.
Discovery explains breast cancer cells’ ability to adapt, surviveJan 28, 2019
A team led by researchers at Baylor College of Medicine has discovered that breast cancer cells can shift between two forms of the cell surface molecule CD44, CD44s and CD44v.
Global grants aim to help scientists understand tumor behaviorJan 23, 2019
A multidisciplinary, international team of scientists has been awarded Cancer Research UK’s Grand Challenge, an ambitious series of £20 million global grants tackling some of the toughest questions in cancer research.
Duncan Cancer Center gets new home at McNairJan 17, 2019
Baylor College of Medicine is consolidating its NCI-designated Dan L Duncan Comprehensive Cancer Center clinics and services into one location on the McNair Campus.
TGF-beta pathway protects against uterine cancerJan 15, 2019
A team of scientists found that the Transforming Growth Factor beta (TGF-beta) signaling pathway in uterine cells protects against uterine cancer by suppressing the overgrowth and transformation into cancer cells of the endometrium.
Bacteria help discover human cancer-causing proteinsJan 10, 2019
A team led by researchers at Baylor College of Medicine and the University of Texas at Austin has applied an unconventional approach that used bacteria to discover human proteins that can lead to DNA damage and promote cancer.
Without Dna2, genes can jump into DNA breaksDec 5, 2018
A study reveals that when Dna2 is absent, small DNA fragments jump from all over the genome into chromosome breaks. This novel mechanism may explain similar events commonly seen in cancer or during antibody diversification.
DPYSL3 an outlier gene in triple-negative breast cancerNov 26, 2018
Researchers have developed an entirely new therapeutic hypothesis on how to treat an aggressive form of triple-negative breast cancer.